Northwestern University medical device spinout Rhaeos raised $10.5 million in Series A funding, CEO Anna Lisa Somera tells Axios exclusively.
Why it matters: The company's wearable patch monitors neuro-surgically implanted shunts, the only current treatment available to people with hydrocephalus. The incurable condition impacts roughly 1 million Americans and is the most common reason for brain surgery in children.
/2023/02/13/1676323718586.gif?w=3840)
